Ionolyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate)

The active ingredients—magnesium chloride hexahydrate, potassium chloride, sodium chloride and sodium acetate trihydrate—dissolve into their respective ions after infusion. These ions are taken up by the extracellular fluid, directly replenishing deficits, stabilising cell membranes, and contributing to acid‑base balance and vascular volume.

The dose of Ionolyte is determined by the prescribing clinician based on the patient’s electrolyte profile, fluid status and clinical condition. The healthcare professional selects the appropriate volume and infusion rate to achieve the desired correction.

Safety data for Ionolyte in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To order Ionolyte, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ionolyte provides a balanced combination of magnesium, potassium, sodium and acetate, whereas many standard saline solutions contain only sodium and chloride. This broader ion profile can address multiple electrolyte deficits in a single infusion, potentially reducing the need for additional supplements.

Ionolyte should be stored at ambient temperature, kept in its original sealed container, protected from direct sunlight, and stored away from moisture. Do not freeze the solution, and inspect for particulate matter before use.

Ionolyte is administered intravenously. The solution is typically infused through a peripheral or central venous line, with the rate adjusted according to the patient’s electrolyte levels, renal function and clinical response, as directed by the prescriber.

Serious risks include severe hypermagnesemia or hyperkalemia, which can cause cardiac arrhythmias or respiratory depression, as well as fluid overload leading to pulmonary edema and rare anaphylactic reactions. Continuous monitoring is essential during infusion.

Ionolyte should be avoided in patients with known hypermagnesemia, hyperkalemia, severe fluid overload, or hypersensitivity to any of its components. Clinicians should also exercise caution in individuals with significant renal impairment or uncontrolled cardiac disease.